AKBA
#3166
Akebia Therapeutics, Inc. - Common Stock
1.3 4 USD
-0.01%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-1.47%
Monthly Change
+41.05%
6 month change
+13.56%
Year Change
+13.56%
Previous Close
1.3 6
Open
1.3 5
Low
1.3 4
High
1.3 7
Volume
580
Financials
- Market Capitalization 359.47 M
- Employee 194
- Founded 2007
- CEO N/A
- Website www.akebia.com
- Headquarter Delaware, United States
- FIGI BBG000R33R00
- Industry Drug Manufacturers—Specialty & Generic
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-17.38
Price to sales ratio
1.6
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3066 |  KMDA Kamada Ltd. - Ordinary Shares | 7.23 USD | -1.09% | -4.99% | -0.69% | -6.71% | 417.07 M USD | ||
| 3095 |  CGC Canopy Growth Corporation - Common Shares | 0.95 USD | 0.00% | -4.04% | -6.86% | -24.00% | 401.05 M USD | ||
| 3303 |  ORGO Organogenesis Holdings Inc. - Class A | 2.43 USD | -2.80% | -0.41% | +2.10% | -43.36% | 312.68 M USD | ||
| 3437 |  TKNO Alpha Teknova, Inc. - Common Stock | 5.23 USD | -3.68% | -13.41% | +12.47% | +3.56% | 280.40 M USD |
Frequently asked questions about Akebia Therapeutics, Inc. - Common Stock
What is the Akebia Therapeutics, Inc. - Common Stock stock price today?
The current price of Akebia Therapeutics, Inc. - Common Stock (AKBA) is 1.34. Over the past 24 hours, the stock has changed by -1.47%. Follow the AKBA chart for real-time price dynamics.
What is the stock ticker of Akebia Therapeutics, Inc. - Common Stock?
Akebia Therapeutics, Inc. - Common Stock trades under the ticker AKBA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Akebia Therapeutics, Inc. - Common Stock stock going up?
AKBA has changed by +8.06% over the last week, +41.05% over the last month, and +13.56% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Akebia Therapeutics, Inc. - Common Stock net income for the last quarter?
Akebia Therapeutics, Inc. - Common Stock reported net income of -9.05 M for the last quarter. The previous quarter showed -12.24 M, which means net income changed by +26.05%.
How many employees does Akebia Therapeutics, Inc. - Common Stock have?
As of the latest available data, Akebia Therapeutics, Inc. - Common Stock has 194 employees. Workforce size can provide additional context about the company's scale and operations.
What is Akebia Therapeutics, Inc. - Common Stock EBITDA?
Akebia Therapeutics, Inc. - Common Stock EBITDA is -4.37 M, and its EBITDA margin is -8.16%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Akebia Therapeutics, Inc. - Common Stock stock?
You can buy Akebia Therapeutics, Inc. - Common Stock (AKBA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Akebia Therapeutics, Inc. - Common Stock stock?
Investing in Akebia Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the AKBA chart and related analysis on metatrader.com as part of your research.